Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

IMRN

Immuron (IMRN)

Immuron Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:IMRN
일자시간출처헤드라인심볼기업
2024/05/3121:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/05/3119:00GlobeNewswire Inc.Immuron Board ChangesNASDAQ:IMRNImmuron Ltd
2024/05/3119:00GlobeNewswire Inc.Immuron CEO Steven Lydeamore to present at Peak Sky HighNASDAQ:IMRNImmuron Ltd
2024/05/0319:00GlobeNewswire Inc.Immuron Director ResignationNASDAQ:IMRNImmuron Ltd
2024/04/1519:00GlobeNewswire Inc.Immuron to host Live Virtual EventNASDAQ:IMRNImmuron Ltd
2024/04/1019:00GlobeNewswire Inc.Immuron Travelan® sales continued strong growthNASDAQ:IMRNImmuron Ltd
2024/03/0722:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/03/0720:00GlobeNewswire Inc.Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USNASDAQ:IMRNImmuron Ltd
2024/02/2822:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/02/2122:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/02/2120:00GlobeNewswire Inc.Immuron Presentation Australian Biologics Festival 2024NASDAQ:IMRNImmuron Ltd
2024/02/1322:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/02/1320:00GlobeNewswire Inc.Immuron achieves record Travelan® salesNASDAQ:IMRNImmuron Ltd
2024/02/0820:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
2024/01/1622:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2024/01/1620:00GlobeNewswire Inc.Immuron achieves record half yearly Travelan® salesNASDAQ:IMRNImmuron Ltd
2023/12/2221:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/12/2220:00GlobeNewswire Inc.Immuron Clinical Trials UpdateNASDAQ:IMRNImmuron Ltd
2023/12/0420:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/12/0420:00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNASDAQ:IMRNImmuron Ltd
2023/11/2820:33GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
2023/11/2820:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/11/2221:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/11/2120:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/11/1408:00GlobeNewswire Inc.Immuron CEO Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
2023/11/1322:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/10/3021:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/10/3020:21GlobeNewswire Inc.Immuron CEO Steven Lydeamore presented at AusBioInvestNASDAQ:IMRNImmuron Ltd
2023/10/2321:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
2023/10/1819:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
 검색 관련기사 보기:NASDAQ:IMRN